Phase II Study of Continued Trastuzumab Plus Irinotecan in Patients with HER2-positive Gastric Cancer Previously Treated with Trastuzumab (HGCSG 1201).
Kawamoto Y, Yuki S, Meguro T, Hatanaka K, Uebayashi M, Nakamura M, Okuda H, Iwanaga I, Kato T, Nakano S, Sato A, Harada K, Oba K, Sakata Y, Sakamoto N, Komatsu Y.
Kawamoto Y, et al. Among authors: yuki s.
Oncologist. 2022 May 6;27(5):340-e374. doi: 10.1093/oncolo/oyab062.
Oncologist. 2022.
PMID: 35303078
Free PMC article.
Clinical Trial.